1.30
+0.21(+19.27%)
Currency In USD
| Previous Close | 1.09 |
| Open | 1.12 |
| Day High | 1.29 |
| Day Low | 1.12 |
| 52-Week High | 11.2 |
| 52-Week Low | 1 |
| Volume | 144,521 |
| Average Volume | 3.29M |
| Market Cap | 6.49M |
| PE | -0.23 |
| EPS | -5.56 |
| Moving Average 50 Days | 1.97 |
| Moving Average 200 Days | 3.41 |
| Change | 0.19 |
If you invested $1000 in Beyond Air, Inc. (XAIR) since IPO date, it would be worth $19.58 as of December 04, 2025 at a share price of $1.155. Whereas If you bought $1000 worth of Beyond Air, Inc. (XAIR) shares 5 years ago, it would be worth $10.28 as of December 04, 2025 at a share price of $1.155.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Beyond Air® Announces Transition of Chief Financial Officer
GlobeNewswire Inc.
Nov 26, 2025 9:30 PM GMT
Launched search for permanent successorGARDEN CITY, N.Y., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the p
Beyond Air® Secures Up to $32 Million to Accelerate Growth
GlobeNewswire Inc.
Nov 05, 2025 1:00 PM GMT
Enters agreements for a $12 million promissory note and a $20 million equity line of credit with Streeterville Capital Proforma cash, cash equivalents, restricted cash and marketable securities of $22.9 million as of September 30, 2025, including $12
Beyond Air Schedules Second Fiscal Quarter 2026 Financial Results Conference Call and Webcast
GlobeNewswire Inc.
Oct 23, 2025 12:00 PM GMT
GARDEN CITY, N.Y., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve th